PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$38.02

Market cap

$214.63B

P/E Ratio

7.35

Dividend/share

$1.62

EPS

$5.17

Enterprise value

$248.36B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
The price to earnings (P/E) is 50% lower than the 5-year quarterly average of 14.7 and 16% lower than the last 4 quarters average of 8.8
Pfizer's equity has increased by 23% YoY and by 6% QoQ
Pfizer's EPS has increased by 16% YoY but it has decreased by 8% from the previous quarter
Pfizer's net income has increased by 16% YoY but it has decreased by 7% QoQ
Pfizer's revenue has decreased by 7% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.pfizer.com/
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.65B
Market cap
$214.63B
Enterprise value
$248.36B
Valuations
Price to earnings (P/E)
7.35
Price to book (P/B)
2.12
Price to sales (P/S)
2.3
EV/EBIT
7.78
EV/EBITDA
6.66
EV/Sales
2.67
Earnings
Revenue
$92.95B
EBIT
$31.92B
EBITDA
$37.29B
Free cash flow
$20.21B
Per share
EPS
$5.17
Free cash flow per share
$3.59
Book value per share
$17.97
Revenue per share
$16.5
TBVPS
$18.13
Balance sheet
Total assets
$195.62B
Total liabilities
$94.38B
Debt
$35.89B
Equity
$100.97B
Working capital
$13.52B
Liquidity
Debt to equity
0.36
Current ratio
1.37
Quick ratio
0.88
Net debt/EBITDA
0.9
Margins
EBITDA margin
40.1%
Gross margin
68.5%
Net margin
31.3%
Operating margin
34.4%
Efficiency
Return on assets
14.8%
Return on equity
30.9%
Return on invested capital
31%
Return on capital employed
20.1%
Return on sales
34.3%
Dividend
Dividend yield
4.26%
DPS
$1.62
Payout ratio
31.3%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
2.73%
1 week
-1.58%
1 month
-2.24%
1 year
-28.32%
YTD
-25.8%
QTD
-6.81%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$92.95B
Gross profit
$63.71B
Operating income
$31.95B
Net income
$29.05B
Gross margin
68.5%
Net margin
31.3%
Pfizer's net income has increased by 16% YoY but it has decreased by 7% QoQ
PFE's net margin is up by 16% YoY
The company's operating margin rose by 15% YoY
The operating income has grown by 15% YoY but it has contracted by 8% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
7.35
P/B
2.12
P/S
2.3
EV/EBIT
7.78
EV/EBITDA
6.66
EV/Sales
2.67
The price to earnings (P/E) is 50% lower than the 5-year quarterly average of 14.7 and 16% lower than the last 4 quarters average of 8.8
Pfizer's EPS has increased by 16% YoY but it has decreased by 8% from the previous quarter
PFE's P/B is 36% below its 5-year quarterly average of 3.3 and 24% below its last 4 quarters average of 2.8
Pfizer's equity has increased by 23% YoY and by 6% QoQ
PFE's P/S is 48% below its 5-year quarterly average of 4.4 and 15% below its last 4 quarters average of 2.7
Pfizer's revenue has decreased by 7% QoQ

Efficiency

How efficient is Pfizer business performance
Pfizer's ROS has increased by 17% YoY
The ROE fell by 12% QoQ and by 6% YoY
The company's return on invested capital rose by 12% YoY but it fell by 8% QoQ
Pfizer's ROA has decreased by 9% from the previous quarter but it has increased by 6% YoY

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.62
Dividend yield
4.26%
Payout ratio
31.3%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 107% greater than its total liabilities
The current ratio has grown by 12% from the previous quarter
The quick ratio has grown by 10% from the previous quarter but it has contracted by 7% YoY
PFE's debt is 64% less than its equity
Pfizer's equity has increased by 23% YoY and by 6% QoQ
The debt to equity has contracted by 18% YoY and by 2.7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.